A real-world ten-week follow-up of the COVID outbreak in an outpatient drug clinic in Salamanca (Spain).


Journal

Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909

Informations de publication

Date de publication:
06 2021
Historique:
received: 09 07 2020
revised: 06 11 2020
accepted: 19 01 2021
entrez: 21 5 2021
pubmed: 22 5 2021
medline: 2 7 2021
Statut: ppublish

Résumé

To compare over ten weeks the number of relapses, hospital admissions, calls made, admissions to therapeutic communities, face-to-face visits, treatment adjustment, number of injectables administered, and number of emergencies attended due to emotional and behavioral alterations and/or substance use disorder, and to describe and quantify social emergencies in an outpatient drug clinic (ODC) in Salamanca (Spain) from March 16, 2020, to May 22, 2020. This is an ecological study of the COVID pandemic over ten weeks. The study examines the set of alcohol or other drug-dependent or dual disorder patients in the population of Salamanca, Spain. The measurements were: professionals; calls made; percentage of successful calls; face-to-face visits; first visits made; reviews made; techniques; injectable treatments; other treatments; evolution; relapses. The ODC includes about 375 new patients each year and another 650 other patients annually. The study found the number of relapses to be greater in the last five weeks of the 10-week study period. Patients' psychopathological instability also increased, and face-to-face visits were necessary. The most frequent psychopathology that required face-to-face intervention was depressive disorder. The number of interventions with patients increased. In parallel, social workers' efforts were greater after the seventh week. There was a decrease in response to calls. Throughout this time, the ODC attended to patients who needed to be treated for the first time. Confinement due to the coronavirus pandemic generated maladaptive emotional responses and other behaviors, such as excessive alcohol consumption. The number of face-to-face consultations, admissions, and referrals to therapeutic communities increased. Patients under stress and in social isolation resorted more often to substance use. The ODC had to adopt a flexible approach to evaluate patients with more serious problems, by using face-to-face assessments.

Identifiants

pubmed: 34016295
pii: S0740-5472(21)00029-5
doi: 10.1016/j.jsat.2021.108303
pmc: PMC8065063
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108303

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Psychiatry Res. 2020 Aug;290:113112
pubmed: 32460185
J Neurol Sci. 2020 Jun 15;413:116832
pubmed: 32299017
J Telemed Telecare. 2006;12(5):251-4
pubmed: 16848938
JAMA Psychiatry. 2020 Nov 1;77(11):1093-1094
pubmed: 32275300
Int J Biol Sci. 2020 Mar 15;16(10):1732-1738
pubmed: 32226291
Actas Esp Psiquiatr. 2019 Mar;47(2):37-44
pubmed: 31017271
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
World J Psychiatry. 2015 Sep 22;5(3):286-304
pubmed: 26425443
Psychiatry Res. 2020 Sep;291:113252
pubmed: 32623263
J Sex Med. 2019 Dec;16(12):1895-1899
pubmed: 31735615
Addict Behav. 2020 Jul;106:106353
pubmed: 32087474
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Psychiatry Clin Neurosci. 2020 Oct;74(10):551-552
pubmed: 32639089
Soc Sci Med. 2015 Apr;131:131-46
pubmed: 25771482
Asian J Psychiatr. 2020 Jun;51:102064
pubmed: 32305033
Subst Use Misuse. 2005;40(2):187-209
pubmed: 15770884
Psychiatry Res. 2020 Jul;289:113041
pubmed: 32388417
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
Front Psychiatry. 2020 Feb 03;10:1028
pubmed: 32116829
J Korean Med Sci. 2020 May 04;35(17):e161
pubmed: 32356422
Lancet. 2020 Feb 29;395(10225):684-685
pubmed: 32078803
Lancet Public Health. 2018 Dec;3(12):e567-e575
pubmed: 30389570
AIDS Care. 2017 Dec;29(12):1551-1556
pubmed: 28393548
Addiction. 2020 Jun;115(6):1007-1010
pubmed: 32250482
Mayo Clin Proc. 2019 Dec;94(12):2510-2523
pubmed: 31806104
Psychiatry Res. 2020 May;287:112915
pubmed: 32199182
Addict Behav. 2006 Apr;31(4):606-21
pubmed: 15982827
J Nerv Ment Dis. 2004 Dec;192(12):823-9
pubmed: 15583503
Addiction. 2000 Apr;95(4):529-36
pubmed: 10829329
Ir J Psychol Med. 2020 Sep;37(3):164-168
pubmed: 32434597
Int J Soc Psychiatry. 2020 Aug 21;:20764020950770
pubmed: 32820986
Ir J Psychol Med. 2020 Dec;37(4):250-255
pubmed: 32434596
Actas Esp Psiquiatr. 2019 Jul;47(4):127-36
pubmed: 31461152
Emerg Infect Dis. 2020 Jun;26(6):1320-1323
pubmed: 32125269
Ann Intern Med. 2020 Jul 7;173(1):61-62
pubmed: 32240293
Front Psychiatry. 2020 Apr 15;11:268
pubmed: 32351413
Psychiatry Res. 2020 Jan 21;285:112805
pubmed: 32035375
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003

Auteurs

Lourdes Aguilar (L)

Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Begoña Vicente-Hernández (B)

Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Diego Remón-Gallo (D)

Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Llanyra García-Ullán (L)

Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Isabel Valriberas-Herrero (I)

Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Ana Maciá-Casas (A)

Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Ana Pérez-Madruga (A)

Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Maria Ángeles Garzón (MÁ)

Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Ana Álvarez-Navares (A)

Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Carlos Roncero (C)

Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain. Electronic address: croncero@saludcastillayleon.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH